EGFR and breast cancer: Given that both of the MCF7-BP1 and T47D-BP1 had higher levels of EGFR, phospho-EGFR, and phospho-Erk, it was hypothesized that the long-term exposure to IGFBP-1 was sufficient for the development of tamoxifen resistance in breast cancer cells.